CD34 and lymphoma: Others have shown that lymphoma patients’ poor mobilization of autologous stem cells, defined as the inability to obtain ≥1 × 106 CD34+ cells/kg body weight, resulted in substantially lower PFS and OS compared with good mobilizers [14, 15].